Enova (NYSE: ENVA) CFO receives new RSU and stock option grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Enova International’s Chief Financial Officer, Cornelis Scott, reported equity awards granted on February 11, 2026. He acquired 3,276 shares of common stock as a grant of restricted stock units at a price of $0 per share, bringing his directly held common stock to 11,091 shares.
He also received 2,105 non-qualified stock options with a limited stock appreciation right at an exercise price of $157.79 per share, expiring on February 11, 2033. The restricted stock units vest in four equal annual installments starting February 11, 2027, while the options vest in three equal annual installments beginning the same date, subject to continued employment.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Cornelis Scott
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) with limited SAR | 2,105 | $0.00 | -- |
| Grant/Award | Common stock, par value $0.00001 per share | 3,276 | $0.00 | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) with limited SAR — 2,105 shares (Direct);
Common stock, par value $0.00001 per share — 11,091 shares (Direct)
Footnotes (1)
- This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028, February 11, 2029 and February 11, 2030. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028 and February 11, 2029.
FAQ
What insider transactions did Enova (ENVA) report for its CFO on February 11, 2026?
Enova’s Chief Financial Officer, Cornelis Scott, reported equity grants on February 11, 2026. He received 3,276 restricted stock units of common stock at $0 and 2,105 non-qualified stock options, both recorded as direct ownership awards rather than open-market purchases or sales.
What are the terms of the restricted stock units granted to Enova (ENVA) CFO Cornelis Scott?
The 3,276 restricted stock units granted to Enova CFO Cornelis Scott vest in four substantially equal installments. Vesting dates are February 11, 2027, 2028, 2029, and 2030, and each tranche requires that he remain an employee of Enova or an affiliate through the applicable vesting date.
What stock options did Enova (ENVA) grant to its CFO, and when do they expire?
Enova granted its CFO 2,105 non-qualified stock options with a limited stock appreciation right at an exercise price of $157.79 per share. These options expire on February 11, 2033 and vest in three substantially equal annual installments beginning February 11, 2027, subject to continued employment.
How do the stock appreciation rights attached to Enova (ENVA) CFO’s options work?
The limited stock appreciation right is paired with the employee stock option, so exercising one cancels the other. The SAR becomes exercisable only after a defined Change in Control and within 30 days, paying value based on Offer Value Per Share and option exercise price if a qualifying Offer occurs.